Zacks Investment Research cut shares of Select Medical (NYSE:SEM) from a hold rating to a sell rating in a research report released on Wednesday morning.
According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “
A number of other research firms also recently commented on SEM. Deutsche Bank reaffirmed a buy rating and issued a $22.00 target price on shares of Select Medical in a research report on Monday, November 6th. Royal Bank of Canada reaffirmed a buy rating and issued a $19.00 target price on shares of Select Medical in a research report on Wednesday, September 13th. ValuEngine raised shares of Select Medical from a hold rating to a buy rating in a research report on Friday, September 1st. Finally, Robert W. Baird reaffirmed a buy rating and issued a $21.00 target price on shares of Select Medical in a research report on Tuesday, October 17th. Two analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of $19.50.
Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, November 2nd. The health services provider reported $0.14 EPS for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The firm had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the prior year, the company posted $0.06 earnings per share. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. equities research analysts anticipate that Select Medical will post 0.85 earnings per share for the current year.
In related news, insider Michael E. Tarvin sold 18,500 shares of the stock in a transaction on Monday, October 30th. The shares were sold at an average price of $18.97, for a total value of $350,945.00. Following the transaction, the insider now directly owns 340,044 shares of the company’s stock, valued at approximately $6,450,634.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Martin F. Jackson sold 156,603 shares of the stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $17.06, for a total transaction of $2,671,647.18. Following the completion of the transaction, the insider now directly owns 1,790,601 shares in the company, valued at $30,547,653.06. The disclosure for this sale can be found here. Insiders sold a total of 180,103 shares of company stock worth $3,112,442 over the last ninety days. Insiders own 19.93% of the company’s stock.
A number of large investors have recently modified their holdings of the stock. Cubist Systematic Strategies LLC acquired a new stake in Select Medical during the 3rd quarter worth $1,748,000. Point72 Asset Management L.P. acquired a new stake in Select Medical during the 3rd quarter worth $20,751,000. Affinity Wealth Management acquired a new stake in Select Medical during the 3rd quarter worth $429,000. Orbimed Advisors LLC boosted its stake in Select Medical by 51.3% during the 3rd quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock worth $107,107,000 after purchasing an additional 1,891,100 shares during the period. Finally, Jane Street Group LLC acquired a new stake in Select Medical during the 3rd quarter worth $1,176,000. Hedge funds and other institutional investors own 77.93% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Select Medical (SEM) Cut to Sell at Zacks Investment Research” was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://sportsperspectives.com/2017/12/17/select-medical-sem-cut-to-sell-at-zacks-investment-research.html.
About Select Medical
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.